230 related articles for article (PubMed ID: 20204475)
21. Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins.
Ballatori N; Hammond CL; Cunningham JB; Krance SM; Marchan R
Toxicol Appl Pharmacol; 2005 May; 204(3):238-55. PubMed ID: 15845416
[TBL] [Abstract][Full Text] [Related]
22. Discovery of ZIP transporters that participate in cadmium damage to testis and kidney.
He L; Wang B; Hay EB; Nebert DW
Toxicol Appl Pharmacol; 2009 Aug; 238(3):250-7. PubMed ID: 19265717
[TBL] [Abstract][Full Text] [Related]
23. Role of the SLC22A17/lipocalin-2 receptor in renal endocytosis of proteins/metalloproteins: a focus on iron- and cadmium-binding proteins.
Thévenod F; Herbrechter R; Schlabs C; Pethe A; Lee WK; Wolff NA; Roussa E
Am J Physiol Renal Physiol; 2023 Nov; 325(5):F564-F577. PubMed ID: 37589051
[TBL] [Abstract][Full Text] [Related]
24. Involvement of intestinal calcium transporter 1 and metallothionein in cadmium accumulation in the liver and kidney of mice fed a low-calcium diet.
Min KS; Ueda H; Tanaka K
Toxicol Lett; 2008 Jan; 176(1):85-92. PubMed ID: 18054826
[TBL] [Abstract][Full Text] [Related]
25. Silencing of ZnT-1 expression enhances heavy metal influx and toxicity.
Ohana E; Sekler I; Kaisman T; Kahn N; Cove J; Silverman WF; Amsterdam A; Hershfinkel M
J Mol Med (Berl); 2006 Sep; 84(9):753-63. PubMed ID: 16741752
[TBL] [Abstract][Full Text] [Related]
26. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
[TBL] [Abstract][Full Text] [Related]
27. Zinc as a countermeasure for cadmium toxicity.
Yu HT; Zhen J; Leng JY; Cai L; Ji HL; Keller BB
Acta Pharmacol Sin; 2021 Mar; 42(3):340-346. PubMed ID: 32284539
[TBL] [Abstract][Full Text] [Related]
28. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
Vaidya SS; Walsh SW; Gerk PM
Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
[TBL] [Abstract][Full Text] [Related]
29. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
30. Regulation of metal transporters by dietary iron, and the relationship between body iron levels and cadmium uptake.
Kim DW; Kim KY; Choi BS; Youn P; Ryu DY; Klaassen CD; Park JD
Arch Toxicol; 2007 May; 81(5):327-34. PubMed ID: 17031680
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
32. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
Miller DS
Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
[TBL] [Abstract][Full Text] [Related]
33. Maitotoxin stimulates Cd influx in Madin-Darby kidney cells by activating Ca-permeable cation channels.
Olivi L; Bressler J
Cell Calcium; 2000 Apr; 27(4):187-93. PubMed ID: 10858664
[TBL] [Abstract][Full Text] [Related]
34. Cadmium uptake by kidney distal convoluted tubule cells.
Friedman PA; Gesek FA
Toxicol Appl Pharmacol; 1994 Oct; 128(2):257-63. PubMed ID: 7524195
[TBL] [Abstract][Full Text] [Related]
35. Cellular mechanisms of cadmium toxicity related to the homeostasis of essential metals.
Moulis JM
Biometals; 2010 Oct; 23(5):877-96. PubMed ID: 20524046
[TBL] [Abstract][Full Text] [Related]
36. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
37. Transport of amphipathic anions by human multidrug resistance protein 3.
Zeng H; Liu G; Rea PA; Kruh GD
Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
[TBL] [Abstract][Full Text] [Related]
38. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
Bucher S; Le Vee M; Jouan E; Fardel O
J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
[TBL] [Abstract][Full Text] [Related]
39. High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells.
Karlsson JE; Heddle C; Rozkov A; Rotticci-Mulder J; Tuvesson O; Hilgendorf C; Andersson TB
Drug Metab Dispos; 2010 Apr; 38(4):705-14. PubMed ID: 20071452
[TBL] [Abstract][Full Text] [Related]
40. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
